Tanso Biosciences is proud to announce that the United States Patent and Trademark Office (USPTO) has officially granted a patent (Patent No. US-12247244-B2) for its innovation to perform functional assays for G protein-coupled receptors (GPCRs). This patent protects Tanso Biosciences' proprietary assay platform and reinforces the company's dedication to advancing drug discovery.
GPCRs play a vital role in numerous physiological processes and are among the most significant classes of drug targets in modern pharmacology. Tanso Biosciences' newly patented technology offers a cutting-edge, highly reliable approach to assessing GPCR functionality, enabling more efficient and accurate drug screening and development.
